Amgen Inc - Tax Provision

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Tax-Provision" stands at 1.24 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2020.

Amgen Inc's third quarter result of 0.705 Billion USD for the item "Tax Provision" represents an increase of 418.38 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 0.705 Billion USD for the item "Tax Provision" represents an increase of 160.15 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 1.24 Billion USD for the item "Tax Provision" represents an increase of 53.91 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 175.95 percent compared to the value the year prior.
The 1 year change in percent is 175.95.
The 3 year change in percent is 38.59.
The 5 year change in percent is 39.68.
The 10 year change in percent is 34.97.

The Serie's long term average value is 1.33 Billion United States Dollars. It's latest available value, on 09/30/2025, is 7.11 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is +573.37%.
The Serie's change in percent from it's maximum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is -83.74%.